Dana Faber Cancer Institute/ Boston Children's Hospital is a clinical research site located in Boston, Massachusetts, United States 02215.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Dana Faber Cancer Institute/ Boston Children's Hospital has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: B-cell Acute Lymphoblastic Leukemia.
Sponsors: Pediatric Transplantation & Cellular Therapy Consortium.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Dana Faber Cancer Institute/ Boston Children's Hospital has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Dana Faber Cancer Institute/ Boston Children's Hospital has 1 clinical trials on record, with 1 currently active. Their work covers B-cell Acute Lymphoblastic Leukemia.
Dana Faber Cancer Institute/ Boston Children's Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.